Lucius Pharmaceuticals Laos

Lucius Pharmaceuticals Laos Lucius Pharmaceutical is a factory focused on providing effective, reliable medications for patients,A factory that produces anti-cancer drugs

11/05/2026

Today's factory visit
Laos Lucius Pharmaceutical Canteen
Let's see what they had for lunch today





08/05/2026

Lucius Pharmaceutical Factory (Laos), Canteen, Today’s Menu




06/05/2026

Lucius Pharmaceutical Factory · The Most Beautiful Sunset



05/05/2026

Zongertinib (Hernexeos): New Hope for HER2-Mutant NSCLC
Zongertinib (brand: Hernexeos) is a breakthrough oral targeted therapy for HER2 mutation-positive non-small cell lung cancer (NSCLC).
✅ Highly selective: blocks mutant HER2, spares healthy EGFR (fewer side effects like rash/diarrhea)
✅ Oral once-daily: easy to take, no IV infusion✅ Strong efficacy: ORR ~71–77%, median PFS ~12.4 months
✅ Brain activity: effective even in patients with brain metastases
For adults with unresectable/metastatic HER2-mutant NSCLC (pretreated or first-line).

09/04/2026

Lucius pharmaceuticals factory in Laos

07/03/2026

Welcome to Lucius Pharmaceutical Factory. We specialize in a variety of anti-tumor targeted drugs, chemotherapeutic drugs and immunotherapeutic drugs, protecting health with professionalism.


02/03/2026

a third-generation EGFR tyrosine kinase inhibitor for EGFR-mutated non-small cell lung cancer (NSCLC). It is indicated for first-line treatment, adjuvant therapy after surgery, and for patients with T790M mutation. It crosses the blood-brain barrier and provides consistent clinical benefit across stages.
Disclaimer: For educational purposes only. Not medical advice.

19/02/2026

Lucius Pharmaceuticals Laos Publicity introduction

Our factory and office
25/01/2026

Our factory and office

Address

老挝
Vientiane
100024

Alerts

Be the first to know and let us send you an email when Lucius Pharmaceuticals Laos posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share